UK Neuromuscular Translational Research Conference 2022 (NTRC)

Back

FORCE™ Platform Delivers Exon Skipping PMO, Leads to Durable Increases in Dystrophin Protein in mdx Mice, and is Well Tolerated in NHPs (poster)

View

DYNE-101 Achieves Durable Knockdown of Toxic Human Nuclear DMPK RNA and Correction of Splicing in the hTfR1/DMSXL Mouse Model of DM1 (poster)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.